Editor’s observe: Discover the newest COVID-19 information and steering in Medscape’s Coronavirus Useful resource Heart.
The most important US doctor group has created a billing code for what’s anticipated to be the nation’s third COVID-19 vaccine, transferring forward of an anticipated regulatory submitting for emergency clearance of the product.
The American Medical Affiliation (AMA) on Tuesday mentioned the Present Procedural Terminology (CPT) code set has been up to date to incorporate the Johnson & Johnson (J&J) /Janssen vaccine, which has been assigned the code 91303.
New Brunswick, New Jersey–primarily based J&J is awaiting section three knowledge from a research of its single-dose vaccine, which could possibly be out there as early as late January, an organization spokesman informed Medscape Medical Information on Wednesday.
If the vaccine continues to look like protected and efficient, J&J will file with the US Meals and Drug Administration (FDA) for emergency use authorization (EUA) of the vaccine “shortly” after seeing these knowledge. The FDA in December granted EUAs for 2 COVID-19 vaccines — the primary from the Pfizer–BioNTech collaboration and the second from Moderna Inc.
“The change will place better significance on precisely reporting COVID-19 immunizations by vaccine sort and dose to make sure sufferers full the suitable immunization schedule,” Bailey mentioned. “Distinctive CPT codes that clinically distinguish every COVID-19 vaccine present the wanted informational precision to make sure optimum vaccine distribution and administration.”
The New England Journal of Medication revealed interim section 1/2a trial outcomes January 13 for J&J’s vaccine. After a single vaccination, neutralizing antibodies towards COVID-19 have been detected in additional than 90% of research contributors at day 29, Jerald Sadoff, MD, and coauthors reported.
It’s anticipated that an EUA clearance for the single-dose J&J product would possibly considerably enhance the general variety of immunizations out there towards COVID-19, Medscape Medical Information reported.
Kerry Dooley Younger is a contract journalist primarily based in Washington, D.C. She earlier lined well being coverage and the federal funds for Congressional Quarterly/CQ Roll Name and the pharmaceutical trade and the Meals and Drug Administration for Bloomberg. Comply with her on Twitter at @kdooleyyoung.
For extra information, comply with Medscape on Fb, Twitter, Instagram, and YouTube.